CXBS — Corix Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Corix Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 January 31st | 2013 January 31st | 2014 January 31st | 2015 January 31st | 2016 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.076 | -1.7 | -1.72 | -0.057 | -4.43 |
| Depreciation | |||||
| Non-Cash Items | 0.006 | 1.68 | 1.7 | 0.02 | 2.37 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.062 | 0.008 | 0.01 | 0.017 | 0.053 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.008 | -0.008 | -0.012 | -0.02 | -1.85 |
| Capital Expenditures | — | — | — | — | -0.028 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.097 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | — | — | — | — | 0.069 |
| Financing Cash Flow Items | 0.008 | 0 | 0 | — | 0.572 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.008 | 0.008 | 0.012 | 0.021 | 1.58 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | -0 | 0 | 0 | -0.197 |